Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Palatin Technologies's book value per share for the quarter that ended in Mar. 2026 was $5.96.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Palatin Technologies was 207.00% per year. The lowest was -48.30% per year. And the median was -21.10% per year.
Palatin Technologies (LTS:0KF3) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Palatin Technologies Book Value per Share Related Terms
Palatin Technologies Book Value per Share Historical Data
* Premium members only.
The historical data trend for Palatin Technologies's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0KF3 vs BIVI, NCEL, KTTA: Book Value per Share Comparison
For the Biotechnology subindustry, Palatin Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Palatin Technologies PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Palatin Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Palatin Technologies's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Palatin Technologies (LTS:0KF3) has a Book Value per Share of $5.96 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Palatin Technologies and its competitors.
Is Palatin Technologies' Book Value per Share too high?
Palatin Technologies' current Book Value per Share is $5.96. Overall, Palatin Technologies has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Palatin Technologies' Book Value per Share compare to BIVI and NCEL?
Palatin Technologies' Book Value per Share of $5.96 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Palatin Technologies and its competitors. Palatin Technologies's current Book Value per Share is $5.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palatin Technologies stock overvalued right now?
Based on GuruFocus' analysis, Palatin Technologies (LTS:0KF3) is currently considered Possible Value Trap. The stock's GF Value™ is $51.03, compared to a current price of $11.14 — trading 78.2% below its estimated fair value. The current Book Value per Share is $5.96. Palatin Technologies' overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Palatin Technologies (LTS:0KF3), the current Book Value per Share is $5.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Palatin Technologies (LTS:0KF3) Overvalued in 2026?
Based on GuruFocus' analysis, Palatin Technologies stock appears to be undervalued.
The current stock price of $11.14 is trading 78.2% below its estimated GF Value™ of $51.03.
GuruFocus considers Palatin Technologies to be Possible Value Trap.
Key valuation signals for LTS:0KF3:
Book Value per Share: $5.96
GF Value™: $51.03 vs. price of $11.14 (78.2% below fair value)
No single metric tells the full story. See the LTS:0KF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Palatin Technologies Inc. is a biopharmaceutical company that develops receptor-specific peptide therapeutics based on molecules that modulate the melanocortin receptor system. Its pipeline targets diseases with unmet medical needs, with programs focused on melanocortin-1 receptor (MC1R) agonists for inflammatory and dermatologic conditions and melanocortin-4 receptor (MC4R) agonists for metabolic and other indications. The company's most commercially advanced product is bremelanotide, an MC4R agonist marketed as Vyleesi for hypoactive sexual desire disorder in premenopausal women, which was approved by the FDA in 2019 and is licensed to a commercial partner in the United States. Palatin operates in a single business segment, life sciences, and generates revenue primarily through licensing fees, milestone payments, royalties, and collaboration agreements rather than direct product sales. The company is headquartered in Cranbury, New Jersey, and its activities are concentrated in the United States.
45GF Score
Get the complete analysis for LTS:0KF3
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0KF3 has been successfully added to your 
